MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
MUSTANG BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.37−0.00 (-0.90%)
Close on Oct 19, 2026
- Market cap
- $2.51M
- P/E (TTM)
- –
- Dividend yield
- –
Mustang Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Market Cap | $2.83M | $197.05M |
| Enterprise Value | -$12.32M | $106.56M |
| PB Ratio | 0.37 | 2.14 |
| P/TBV Ratio | 0.37 | 2.46 |
Income (trailing twelve months)
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Operating Income | -$3.52M | -$21.44M |
| Net Income | -$3.03M | -$22.46M |
| EBITDA | -$3.52M | -$16.91M |
| EPS (Diluted) | -$0.45 | -$0.83 |
Returns
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -58.1% | -53.1% |
| Return on Assets (ROA) | -21.2% | -41.0% |
| Return on Capital Employed (ROCE) | -45.8% | -37.8% |
Balance sheet
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $15.15M | $62.42M |
| Net Cash (Debt) | $15.15M | $15.68M |
| Net Cash Per Share | $2.00 | $0.65 |
| Equity (Book Value) | $7.55M | $48.79M |
| Book Value Per Share | $1.00 | $1.36 |
| Tangible Book Value | $7.55M | $23.06M |
Financial position
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Quick Ratio | 1.91 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$4.51M | -$12.35M |
Efficiency
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$758.25K | -$732.08K |
| Employee Count | 4 | 73 |
Dividends and yields
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Earnings Yield | -107.3% | -21.2% |
Shares
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Shares Outstanding | 7,577,510 | 59,128,900 |
| Shares Change (YoY) | 202.2% | 11.1% |
| Float | 7,037,840 | 48,744,500 |
| Shares Held by Insiders | 7.12% | 11.8% |
| Shares Held by Institutions | 7.11% | 59.4% |
Scores
| Measure | Mustang Bio | Industry median |
|---|---|---|
| Altman Z-Score | -36.46 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Mustang Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.